SAMSUNG BIOLOGICS, the world's largest cell culture facilities
Since 2015,when the collaboration between Samsung Biologics and Pierre Guerin began with an initial order for a bioreactor skid, the two companies have continued this incredible adventure, based on mutual trust, respect and appreciation.
A total of 105 bioreactors have been ordered, to equip:
- First, the P3 plant in Incheon, South Korea, with 6 suites including 12 bioreactors of 15,000L each
- Followed by the P4 plant with 9 suites including 12 bioreactors of 15,000L and 6 bioreactors of 10,000L,
- And finally, in 2022, the P5 plant with 6 suites including 12 bioreactors of15,000L each.
Global production capacity, 600,000L.
